[{"address1": "5005 McConnell Avenue", "city": "Los Angeles", "state": "CA", "zip": "90066", "country": "United States", "phone": "310 665 2928", "fax": "310 665 2963", "website": "https://www.armatapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. Deborah L. Birx M.D.", "age": 67, "title": "CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 554998, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David D. House", "age": 40, "title": "Senior VP of Finance & Principal Financial Officer", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 352231, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pierre  Kyme Ph.D.", "age": 46, "title": "Chief Business Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 733062, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Hubbard", "title": "Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.ampliphibio.com/phoenix.zhtml?c=84981&p=irol-stockquote", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.45, "open": 2.4268, "dayLow": 2.54, "dayHigh": 2.54, "regularMarketPreviousClose": 2.45, "regularMarketOpen": 2.4268, "regularMarketDayLow": 2.54, "regularMarketDayHigh": 2.54, "payoutRatio": 0.0, "beta": 0.947, "forwardPE": -1.6178343, "volume": 2241, "regularMarketVolume": 2241, "averageVolume": 247943, "averageVolume10days": 9510, "averageDailyVolume10Day": 9510, "bid": 2.45, "ask": 2.55, "bidSize": 1, "askSize": 2, "marketCap": 91931488, "fiftyTwoWeekLow": 0.9, "fiftyTwoWeekHigh": 2.96, "priceToSalesTrailing12Months": 19.564054, "fiftyDayAverage": 2.1176, "twoHundredDayAverage": 1.97955, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 214901440, "profitMargins": -0.09066, "floatShares": 10838137, "sharesOutstanding": 36193500, "sharesShort": 67235, "sharesShortPriorMonth": 134133, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0019, "heldPercentInsiders": 0.69552004, "heldPercentInstitutions": 0.02131, "shortRatio": 3.45, "shortPercentOfFloat": 0.0063, "impliedSharesOutstanding": 36193500, "bookValue": -1.486, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -426000, "trailingEps": -0.4, "forwardEps": -1.57, "lastSplitFactor": "1:14", "lastSplitDate": 1557446400, "enterpriseToRevenue": 45.733, "enterpriseToEbitda": -5.508, "52WeekChange": 0.099567056, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 2.54, "targetHighPrice": 9.0, "targetLowPrice": 9.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 11688000, "totalCashPerShare": 0.323, "ebitda": -39014000, "totalDebt": 134658000, "quickRatio": 0.108, "currentRatio": 0.119, "totalRevenue": 4699000, "revenuePerShare": 0.13, "returnOnAssets": -0.24324, "grossProfits": -27140000, "freeCashflow": -30482876, "operatingCashflow": -34547000, "revenueGrowth": -0.492, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -16.68228, "financialCurrency": "USD", "symbol": "ARMP", "language": "en-US", "region": "US", "typeDisp": "Equity", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Armata Pharmaceuticals, Inc.", "longName": "Armata Pharmaceuticals, Inc.", "postMarketChangePercent": -4.3307047, "postMarketPrice": 2.43, "postMarketChange": -0.109999895, "regularMarketChange": 0.0899999, "regularMarketDayRange": "2.54 - 2.54", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 247943, "fiftyTwoWeekLowChange": 1.64, "fiftyTwoWeekLowChangePercent": 1.8222222, "fiftyTwoWeekRange": "0.9 - 2.96", "fiftyTwoWeekHighChange": -0.42000008, "fiftyTwoWeekHighChangePercent": -0.14189191, "fiftyTwoWeekChangePercent": 9.956705, "dividendDate": 1557446400, "earningsTimestamp": 1747253108, "earningsTimestampStart": 1755201600, "earningsTimestampEnd": 1755201600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.4, "epsForward": -1.57, "epsCurrentYear": -1.94, "priceEpsCurrentYear": -1.3092782, "fiftyDayAverageChange": 0.4224, "fiftyDayAverageChangePercent": 0.1994711, "twoHundredDayAverageChange": 0.56044996, "twoHundredDayAverageChangePercent": 0.2831199, "priceToBook": -1.7092867, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "corporateActions": [], "postMarketTime": 1754082300, "regularMarketTime": 1754074708, "exchange": "ASE", "messageBoardId": "finmb_84546611", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.67347, "regularMarketPrice": 2.54, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 769440600000, "cryptoTradeable": false, "displayName": "Armata Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]